Compare BAND & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BAND | CYRX |
|---|---|---|
| Founded | 2000 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 395.6M | 421.6M |
| IPO Year | 2017 | 2008 |
| Metric | BAND | CYRX |
|---|---|---|
| Price | $15.58 | $8.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $20.40 | $12.94 |
| AVG Volume (30 Days) | ★ 428.8K | 321.3K |
| Earning Date | 05-22-2026 | 06-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.68 |
| Revenue | $204,113,000.00 | ★ $228,385,000.00 |
| Revenue This Year | $17.15 | $9.71 |
| Revenue Next Year | $7.39 | $9.56 |
| P/E Ratio | ★ N/A | $5.07 |
| Revenue Growth | ★ 25.26 | N/A |
| 52 Week Low | $11.33 | $4.63 |
| 52 Week High | $18.63 | $11.45 |
| Indicator | BAND | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 64.67 | 49.94 |
| Support Level | $15.02 | $8.16 |
| Resistance Level | $16.64 | $9.31 |
| Average True Range (ATR) | 0.96 | 0.47 |
| MACD | 0.25 | 0.07 |
| Stochastic Oscillator | 76.59 | 86.01 |
Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of the company's revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.